Location History:
- Erstein, FR (1997)
- Strasbourg, FR (1997 - 2010)
Company Filing History:
4 out of 1,745 
2 out of 5,094 
1 out of 3,685 
Years Active: 1997-2010
Title: **Diane J Mathis: Trailblazer in Arthritis Research**
Introduction
Diane J Mathis, based in Strasbourg, France, is a distinguished inventor known for her significant contributions to the field of arthritis research. With a total of four patented innovations, her work primarily focuses on innovative diagnostic and therapeutic strategies for managing arthritis.
Latest Patents
Diane J Mathis's most recent patents explore the use of glucose-6-phosphate isomerase and related antibodies for both diagnosis and therapy of arthritis. Her patents include pioneering methods for isolating monoclonal antibodies specifically capable of targeting this protein. This research not only enhances the understanding of arthritis but also holds the potential for developing effective anti-arthritic compounds.
Career Highlights
Throughout her professional journey, Diane has made impactful contributions while working at esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé Et De La Recherche Médicale) and the National Center for Scientific Research (Centre National De La Recherche Scientifique). Her affiliations with these organizations underscore her commitment to advancing medical research and innovation.
Collaborations
Diane J Mathis has collaborated with notable researchers in her field, including Christophe O Benoist and Isao Matsumoto. These collaborations have played a pivotal role in furthering her work, enabling her to combine expertise and resources to tackle complex challenges in arthritis treatment and diagnosis.
Conclusion
In conclusion, Diane J Mathis stands as a prominent figure in the realm of arthritis research and innovation. Her patents not only reflect her ingenuity as an inventor but also promise significant advancements in the diagnostic and therapeutic approaches to arthritis. Through her continued efforts, the landscape of arthritis treatment is being transformed, benefiting many individuals affected by this condition.